Reckitt Benckiser Group plc (LON:RKT – Get Free Report)’s stock price traded up 2.6% on Thursday . The company traded as high as GBX 6,300 and last traded at GBX 6,289. 4,216,770 shares changed hands during trading, a decline of 49% from the average session volume of 8,225,884 shares. The stock had previously closed at GBX 6,127.
Wall Street Analyst Weigh In
A number of analysts have recently commented on the stock. Jefferies Financial Group boosted their target price on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 5,700 and gave the stock a “hold” rating in a research note on Wednesday, January 7th. JPMorgan Chase & Co. boosted their price objective on Reckitt Benckiser Group from GBX 5,500 to GBX 6,100 and gave the stock a “neutral” rating in a research note on Wednesday, November 26th. Royal Bank Of Canada downgraded Reckitt Benckiser Group to a “sector perform” rating and decreased their target price for the company from GBX 6,400 to GBX 6,200 in a research report on Wednesday, January 14th. UBS Group reiterated a “buy” rating and set a GBX 7,700 price target on shares of Reckitt Benckiser Group in a research report on Friday, October 17th. Finally, Citigroup started coverage on Reckitt Benckiser Group in a research note on Wednesday, January 14th. They issued a “buy” rating and a GBX 7,000 price objective for the company. Three research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of GBX 6,279.29.
View Our Latest Research Report on RKT
Reckitt Benckiser Group Stock Performance
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Read More
- Five stocks we like better than Reckitt Benckiser Group
- Your Bank Account Is No Longer Safe
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- When to buy gold (mathematically)
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
